Header Logo

Connection

Jonathan Watts to Exons

This is a "connection" page, showing publications Jonathan Watts has written about Exons.
Connection Strength

0.100
  1. Gooding JE, Park G, Wagh A, Watts JK, Dominov JA, Brown RH. Peptide-phosphorodiamidate morpholino oligomer therapy for dysferlinopathy induces pseudoexon skipping and restoration of functional protein. JCI Insight. 2026 08 24; 11(16).
    View in: PubMed
    Score: 0.056
  2. Aartsma-Rus A, Garanto A, van Roon-Mom W, McConnell EM, Suslovitch V, Yan WX, Watts JK, Yu TW. Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic Acid Ther. 2023 01; 33(1):17-25.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.